Transaction in Own Shares

Summary by AI ^BETAClose X

Melrose Industries PLC has announced the purchase of 254,135 ordinary shares between April 13th and April 17th, 2026, through Merrill Lynch International. The volume-weighted average prices ranged from 522.31p to 544.46p, with the lowest price per share at 517.20p and the highest at 561.20p. These shares will be held in treasury, bringing the total in treasury to 63,386,828 and the total shares in issue to 1,248,088,493.

Disclaimer*

Melrose Industries PLC

20 April 2026


20ᵗʰ April 2026
Melrose Industries PLC
("Melrose" or the "Company")
Transaction in Own Shares

The Company announces today it has purchased the following number of its ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in the period from 13th April 2026 to 17th April 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (pence)	Highest price per share (p)
13 April 2026	XLON	522.3098	65,000	517.2000	526.2000
14 April 2026	XLON	540.1445	65,000	533.2000	542.8000
15 April 2026	XLON	537.9425	65,000	535.0000	540.8000
16 April 2026	XLON	542.3405	60,000	535.6000	550.0000
17 April 2026	XLON	544.4551	29,135	535.4000	561.2000


The Company intends to hold the purchased shares in treasury.

Following the above transaction, the Company has 63,386,828 ordinary shares in treasury and has 1,248,088,493 ordinary shares in issue (excluding treasury shares).


Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the MLI on behalf of the Company as part of the buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/0093B_1-2026-4-17.pdf

For further information please contact:
Warren Fernandez Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END